448 Results

People

  1. Cheung
    Cheung
  2. Kushner
    Kushner
  3. Zelenetz
    Zelenetz
  4. Kramer
    Kramer
  5. Moskowitz
    Moskowitz
  6. Straus
    Straus
  7. Yahalom
    Yahalom
  8. Sabbatini
    Sabbatini
  9. La Quaglia
    La Quaglia
  10. Modak
    Modak

Groups

  1. Department of Medicine (275)
  2. Center for Hematologic Malignancies (177)
  3. Hematologic Malignancies, Division of (170)
  4. Solid Tumor Oncology Division (109)
  5. Survivorship Research (89)
  6. GSK Faculty (80)
  7. Pediatrics, Department of (78)
  8. Tow Center for Developmental Oncology (TCDO) (73)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (68)
  10. Lymphoma (65)
  1. "cancer regression"
Formats
  1. Journal Article (414)
  2. Conference Paper (12)
  3. Editorial (8)
  4. Review (8)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (275)
  2. Center for Hematologic Malignancies (177)
  3. Hematologic Malignancies, Division of (170)
  4. Solid Tumor Oncology Division (109)
  5. Survivorship Research (89)
  6. GSK Faculty (80)

More Groups

People
  1. Nai-Kong Cheung (35)
  2. Brian Kushner (29)
  3. Andrew Zelenetz (26)
  4. Kim Kramer (23)
  5. Craig Moskowitz (19)
  6. David Straus (18)

More People

Years
  1. 2025 (6)
  2. 2024 (11)
  3. 2023 (13)
  4. 2022 (10)
  5. 2021 (7)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (47)
  2. Blood (27)
  3. Clinical Cancer Research (25)
  4. Cancer (22)
  5. Leukemia and Lymphoma (19)
  6. Biology of Blood and Marrow Transplantation (15)

More Publications

Publishers
  1. Elsevier Inc. (58)
  2. American Society of Clinical Oncology (48)
  3. American Association for Cancer Research (33)
  4. American Society of Hematology (32)
  5. Wiley Blackwell (27)
  6. Taylor & Francis Group (24)

More Publishers

Results (448)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML
    Journal Article

    Ball, B. J.; Xiao, W.; Borthakur, G.; Nguyen, L. X. T.; Valerio, M.; Venkatachalam, A.; Marcucci, G.; Stein, A. S.; Thai, D. L.; Cook, D. N.; more...
    Journal of Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • Consolidation regimen and cerebral atrophy in patients with primary central nervous system lymphoma
    Journal Article

    Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A. S.; Yahalom, J.; Cederquist, G. Y.; Schaff, L. R.; Hatzoglou, V.; Young, R. J.; Payinkay, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
    Journal Article

    Gillessen, S.; Turco, F.; Davis, I. D.; Efstathiou, J. A.; Fizazi, K.; James, N. D.; Shore, N.; Small, E.; Smith, M.; Sweeney, C. J.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor–Induced colitis
    Journal Article

    Thomas, A. S.; Lu, Y.; Campbell, M.; Thompson, J. A.; Tan, D.; Faleck, D. M.; Wang, Y.
    Gastroenterology (2025)

    Fulltext@MSK | Save
  • Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center
    Journal Article

    Liu, Y. L.; Praiss, A. M.; Chiang, S.; Devereaux, K.; Huang, J.; Rizzuto, G.; Al-Rawi, D.; Weigelt, B.; Jewell, E.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab
    Journal Article

    Lochrin, S. E.; Buonocore, D. J.; Young, R. J.; Kaley, T. J.; Postow, M. A.; Wolchok, J. D.; Shoushtari, A. N.; Momtaz, P.; Betof Warner, A. S.; Callahan, M. K.
    Pigment Cell & Melanoma Research (2024)

    Fulltext@MSK | Save
  • Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Research Letter

    Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: A 28-year institutional experience
    Journal Article

    Cowen, E. A.; Barrios, D. M.; Pulitzer, M. P.; Moy, A. P.; Dusza, S. W.; De Wolf, S.; Geyer, M. B.; Markova, A.
    Acta Haematologica (2024)

    Fulltext@MSK | Save
  • Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer
    Journal Article

    Plumber, S. A.; Tate, T.; Al-Ahmadie, H.; Chen, X.; Choi, W.; Basar, M.; Lu, C.; Viny, A.; Batourina, E.; Li, J.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save